Bahl Center Will Transform Personalization of Cancer Care
Pushing the boundaries of high-tech cancer research and treatment, the Stony Brook University Cancer Center will open a new, one-of-a-kind translational research resource that will harness imaging technology to probe the metabolism of tumors.
Made possible by two back-to-back gifts from Kavita and Lalit Bahl totaling $13.75 million, the new Kavita and Lalit Bahl Center for Metabolomics and Imaging advances the family’s vision to elevate Stony Brook Medicine to the cutting-edge of personalized cancer research, diagnostic imaging breakthroughs and evolving individualized cancer care far beyond the status quo.
Metabolomics, an emerging field in cancer investigation, promises breakthroughs in individualized cancer treatment because uncovering metabolic pathways is a key to unlocking their influence on the development and proliferation of cancer cells.
▪ Read Wall Street Journal coverage (subscription required)
Under the guidance of Yusuf Hannun, MD, and Lina Obeid, MD, the Bahl Center brings together Stony Brook researchers in the fields of metabolomics, cancer biology, medical imaging, and computational oncology.
“These gifts establish the Stony Brook University Cancer Center as home to a revolutionary new metabolomics and imaging center devoted to cancer research which will lead to translational breakthroughs,” said Stony Brook University President Samuel L. Stanley Jr., MD.
“The totality of these two incredible gifts from Kavita and Lalit Bahl, both generous and visionary, will have a decades-long impact on cancer research, medical treatments and patient care,” Stanley said. “At the hub of all this is our Cancer Center — connecting a multi-disciplinary team that spans across main campus and the Medicine campus.”